Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1999 | 1 |
2002 | 1 |
2015 | 1 |
2016 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Mast cells in rheumatic disease.
Eur J Pharmacol. 2016 May 5;778:116-24. doi: 10.1016/j.ejphar.2015.03.085. Epub 2015 May 2.
Eur J Pharmacol. 2016.
PMID: 25943290
Review.
Mast cells as a target of rheumatoid arthritis treatment.
Kobayashi Y, Okunishi H.
Kobayashi Y, et al.
Jpn J Pharmacol. 2002 Sep;90(1):7-11. doi: 10.1254/jjp.90.7.
Jpn J Pharmacol. 2002.
PMID: 12396022
Free article.
Review.
We therefore studied the effects of a MC-stabilizing compound, cromoglicate lisetil (CL), which is an orally deliverable prodrug of cromolyn sodium, on the RA disease model. ...
We therefore studied the effects of a MC-stabilizing compound, cromoglicate lisetil (CL), which is an orally deliverable prodr …
Item in Clipboard
[Effects of orally available prodrug of cromoglycic acid on collagen-induced arthritis mice].
Kobayashi Y, Shirahase H, Zhao HF, Kakizoe E, Okunishi H.
Kobayashi Y, et al.
Nihon Yakurigaku Zasshi. 1999 Oct;114 Suppl 1:154P-158P. doi: 10.1254/fpj.114.supplement_154.
Nihon Yakurigaku Zasshi. 1999.
PMID: 10629873
Japanese.
Cromoglicate lisetil (CL) is an orally deliverable prodrug of cromoglycic acid, having diethyl promoieties and a lysyl promoiety for its optimum drug-delivery. ...
Cromoglicate lisetil (CL) is an orally deliverable prodrug of cromoglycic acid, having diethyl promoieties and a lysyl promoie …
Item in Clipboard
Cite
Cite